Finanzen von Sabra Health Care REIT Inc (SBRA)SBRASabra Health Care REIT Inc

Evaluating the bottom line, Sabra Health Care REIT, Inc. maintains a gross margin of 62.43%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -13.59%, while the net margin is -10.70%. These profitability ratios, combined with a Return on Equity (ROE) of 2.40%, provide a clear picture of how effectively SBRA converts its operational activities into shareholder value.

In the context of the broader market, SBRA competes directly with industry leaders such as RITM and CUZ. With a market capitalization of $4.81B, it holds a leading position in the sector. When comparing efficiency, SBRA's gross margin of 62.43% stands against RITM's 65.19% and CUZ's 29.28%. Such benchmarking helps identify whether Sabra Health Care REIT, Inc. is trading at a premium or discount relative to its financial performance.

The company has shown fluctuating financial performance, with a recent net loss of $0.10 per share and a gross margin that has decreased to 62.43% in Q2 2026 from 69.42% in Q4 2024. However, total revenue has been increasing, reaching $235.87 million in Q2 2026, up from $221.75 million in Q1 2026.